Comprehensive Analysis of the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market 2025-2034: Growth Rates, Trends, and Future Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the benign prostatic hyperplasia (bph) treatment devices and equipment market size evolved in recent years?
The market for benign prostatic hyperplasia (BPH) treatment devices and equipment has demonstrated robust growth in recent times. The market value, which stood at $1.29 billion in 2024, is projected to increase to $1.38 billion by 2025, indicating a compound annual growth rate (CAGR) of 7.2%. The significant growth witnessed in the historical period can be attributed to factors such as an aging population, heightened awareness and diagnosis, improved healthcare accessibility, and personalized treatment options.
What are the predictions for the benign prostatic hyperplasia (bph) treatment devices and equipment market size in the coming years?
Growth of the benign prostatic hyperplasia (BPH) treatment devices and equipment market is predicted to be robust in the upcoming years, expanding to a size of $1.8 billion by 2029, with a compound annual growth rate (CAGR) of 6.8%. The surge expected during this forecast period is linked to factors such as minimally invasive methods, expansion in emerging markets, regulatory assistance, and value-based healthcare. Key trends projected for this period encompass non-surgical and office-based procedures, use of laser and radiofrequency technologies, telehealth and distant consultations, and increased patient education and involvement.
Get your benign prostatic hyperplasia (bph) treatment devices and equipment market report here!
https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp
What key factors are fueling the growth of the benign prostatic hyperplasia (bph) treatment devices and equipment market?
The anticipated growth of the benign prostatic hyperplasia market can be attributed to the escalating number of prostate cancer cases. Prostate cancer originates in the prostate gland, a small gland shaped like a walnut located under the bladder in males. This resurgence in prostate cancer cases entails an increasing number of older males turning to medical professionals for prostate-related concerns. This scenario brings to the forefront the diagnosis and management of benign prostatic hyperplasia. For instance, the American Society of Clinical Oncology (ASCO), a prominent organization based in the US that delivers patient information on the cancer.net website reported in February 2023 that an estimated 288,300 males in the United States suffered from prostate cancer in the said year, while there were 268,490 fresh cases and 34,500 fatalities as a result of prostate cancer in 2022. Consequently, the rise in prostate cancer cases is fueling the expansion of the benign prostatic hyperplasia market.
How is the global benign prostatic hyperplasia (bph) treatment devices and equipment market divided into key segments?
The benign prostatic hyperplasia (BPH) treatment devices and equipment market covered in this report is segmented –
1) By Product: Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants
2) By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types
3) By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home
Subsegments:
1) By Resectoscopes: Bipolar Resectoscopes, Monopolar Resectoscopes, High-Performance Resectoscopes
2) By Radiofrequency Ablation Device: Single-Needle Radiofrequency Ablation, Multi-Needle Radiofrequency Ablation
3) By Urology Lasers: Holmium Lasers, Diode Lasers, Green Light Lasers
4) By Prostatic Stents: Temporary Prostatic Stents, Permanent Prostatic Stents
5) By Implants: Prostatic Urethral Lift (PUL) Implants, Balloon-Expandable Stents, Permanent Implants for BPH Treatment
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp
Who are the key firms paving the way for growth in the benign prostatic hyperplasia (bph) treatment devices and equipment market?
Major companies operating in the benign prostatic hyperplasia (BPH) treatment devices and equipment market include Karl Storz, Lumenis Ltd., Olympus Corporation, Urologix LLC, Boston scientific Inc., Endo International plc, NeoTract Inc., OmniGuide Inc., Medifocus Inc., ProArc Medical Ltd., Teleflex Incorporated, Medtronic plc, Urotech Devices, Prostalund Operations AB, Baxter International, NxThera Inc., Richard Wolf GmbH, Coloplast A/S, Siemens Healthineers, Quest Pharmatech, Protox Therapeutics, IntelGenx Technologies Corp, Astellas Pharma Inc., Ipsen S.A., Biolitec AG, BVM Medical, Convergent Laser Technologies, Cook Medical, GreenLight Technologies, Merit Medical Systems, Pnn Medical A/S, PROCEPT BioRobotics, Prosenex, ProSolv CardioVascular Inc., Quanta System, Rocamed SAM, RZ Medizintechnik GmbH, SRS Medical Systems, UroShape LLC, Vertebron Inc.
Which trends are expected to transform the benign prostatic hyperplasia (bph) treatment devices and equipment market?
Leading businesses in the benign prostatic hyperplasia market are concentrating on the production of novel products, such as the UroLift 2 System and the UroLift ATC advanced tissue control system. These tools were introduced to treat lower urinary tract symptoms arising from benign prostatic hyperplasia (BPH). For example, in May 2022, Teleflex Incorporated, an American medical device corporation, introduced the UroLift 2 System and UroLift ATC. The UroLift 2 System is a designed delivery system that can reach the prostatic urethra to permanently install UroLift implants within the prostate lobes. On the other hand, the UroLift ATC advanced tissue control system is a non-invasive procedure to manage symptoms of an enlarged prostate by lifting and holding the swollen prostate tissue so it doesn’t obstruct the urethra. This is a groundbreaking strategy for the treatment of benign prostatic hyperplasia (BPH).
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2431
What regions are contributing significantly to the growth of the benign prostatic hyperplasia (bph) treatment devices and equipment market?
North America was the largest region in the benign prostatic hyperplasia (BPH) treatment devices and equipment market in 2023. Western Europe was the second-largest region in the global benign prostatic hyperplasia (BPH) treatment devices and equipment market. The regions covered in the benign prostatic hyperplasia (BNH) treatment devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Browse Through More Similar Reports By The Business Research Company:
Bioabsorbable Stents Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report
Tumor Ablation Therapy Devices Global Market Report 2024
Nephrology And Urology Devices Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
